STARTUP LEGAL18 Sept 2026
FSSAI initiates legal action against Nestlé over alleged infant food violations | Company Business News
The Food Safety and Standards Authority of India (FSSAI) has begun legal action against Nestlé India in three cases. It says promotional claims for NAN Excella Pro Stage 1 and Lactogen Pro 1 broke infant food rules, and one follow-up formula sample failed biotin testing. Nestlé says it follows all rules. If you sell infant food, review your labels and claims.
Key Statutory Highlights
- FSSAI says the promotional claims for NAN Excella Pro Stage 1 and Lactogen Pro 1 breached Regulation 4(2) of the FSS (Foods for Infant Nutrition) Regulations, 2020 and Section 3 of the IMS Act, 1992.
- A follow-up formula sample manufactured by Nestlé India was found sub-standard on Biotin content and the Referral Laboratory also found it non-conforming on the prescribed Biotin requirement.
- Nestlé India said its products are fully compliant with applicable regulations and that the labels of NAN Excella Pro and Lactogen Pro were approved by an expert committee of FSSAI.
- Shares of Nestle India settled about 1.4% lower at ₹1,353.10 apiece on the BSE on Friday.
Actionable Advice for Taxpayers / Founders:If you sell or market infant nutrition products, get your labels and e-commerce promotional claims reviewed by a food law professional before you run them, since claims about ingredients can invite regulatory scrutiny under the infant food rules.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: